FAQ • Schedule • Posters • Resources • Networking • Supporters • Shining Light

CPNP 2021 Scientific Poster Session Abstracts

Below is a complete list of the posters that will be presented at CPNP 2021. There will be two different poster sessions, and award finalists will present their posters on the same day as their platform presentation.

Click on the column headings to sort the table below, or click on a keyword next to a poster to filter by specific topic.

Use the search box to quickly locate an abstract by any data in the column, including "PGY2"! The site search provides full-text search of all 2,900+ abstracts that have been presented at the CPNP Annual Meeting over the years. For a brief video introduction to the poster session technology, see the FAQ.

Title
A Breath of Fresh Air: Treatment of Intramuscular Naltrexone-Induced Eosinophilic Pneumonia
A Combination of Olanzapine and Samidorphan in Adults With Schizophrenia and Bipolar I Disorder: Overview of Clinical Data
A Comparison of Erenumab versus Botulinum among Veterans with Chronic Migraines in the setting of COVID-19
A Comparison of Prazosin and Topiramate for the Treatment of Alcohol Use Disorder in Veterans with PTSD
A Comparison of the Pharmacokinetics, Efficacy, and Tolerability of Long-Acting Injectable Risperidone Formulations
A Pharmacist-Developed Algorithm to Improve UTI Antibiotic Appropriateness at an Inpatient Psychiatric Hospital
A Retrospective Study Evaluating the Role of Atomoxetine in Improving Outcomes in Patients with Attention Hyperactivity Disorder and Comorbid Substance Use Disorder
A Retrospective Study of Pharmacist versus Psychiatrist-Led Medication Management in an Outpatient Setting
A Survey of Health Care Professionals: Is a New Nomenclature Needed for Atypical Antipsychotics?
Access to Medications for Opioid Use Disorder Within Integrated Healthcare Systems: Barriers and Potential Solutions
Addition of a Clinical Pharmacy Specialist to an Inpatient Addiction Triage Team and Related Medication Outcomes
Adjusting Long Acting Injectable Antipsychotic Regimens to Reduce Patient and Clinician Risk During the COVID-19 Pandemic
Adverse Effects of Combination Antipsychotic Therapy in a Forensic Patient Population
Alcohol Use Disorder Pharmacotherapy Education for Veterans Hospitalized for Acute Withdrawal Management
Alcohol Use Education and Alcohol Use Disorder Pharmacotherapy Management in Primary Care
Analysis of Patient-Reported Satisfaction with Long-Acting Injectables for Opioid and Alcohol Use Disorder in a Central Texas Outpatient Clinic
Analysis of Pharmacy Student's and Professional's Perception of Efficacy and Risk of Psychotropic Medications Through Estimated Number-needed-to-treat and Number-needed-to harm
Analysis Of Student Pharmacists’ Self-Reported Intention To Provide Harm Reduction Resources After Brief Education And A Simulated Patient Encounter
Analysis of Trends in Anxiety in Professional Pharmacy Students; A Follow-up Study: Evaluating the relationship between Anxiety and caffeine intake, hours of sleep, and perceived loneliness in Professional Pharmacy Students.
Analyzing the Effect of Art Therapy Interventions and Wellness Programs on Graduate Pharmacy Students’ Mental Health
Anticholinergic use and antipsychotic initiation in dementia: an evaluation of prescribing at a Veterans Affairs Medical Center
Antipsychotic Use at a Skilled Nursing Facility
Anxiety in Professional Pharmacy Students: A Literature Review on Anxiety and Effective Coping Mechanisms
Assessing Adherence and Persistence to Long-Acting Injectable Antipsychotics Initiated in the Inpatient Setting
Assessing Patient-Reported Outcomes and Pharmacist Interventions in Neurology Specialty Disease States within an Integrated Care Center
Assessing the characteristics of Veterans over 65 who are prescribed benzodiazepines: comparing Veterans in mental health clinics and primary care clinics
Assessing the Clinical Outcomes surrounding Deep Brain Stimulation in the Treatment of Refractory Obsessive-Compulsive Disorder: A Case-Cohort Study
Assessing the Need for Gender Diverse Education Amongst Practicing Community Pharmacists
Assessing the prevalence of drugs listed in American Geriatric Society Beers Criteria for Potentially Inappropriate Medication Use in non-critically ill hospitalized geriatric patients
Assessing Use of Population Management Tools to Promote Safety for Long-Acting Injectable Psychotropic Medications
Assessment of a Comprehensive Naloxone Education Program’s Impact on Community Member Knowledge and Attitudes on a College Campus
Assessment of Anticholinergic Polypharmacy in the Elderly at a Community Psychiatric Hospital
Assessment of Hepatitis C Treatment Sustained Virologic Response in Veterans with Substance Use and Prevalence of Reinfection
Assessment of Monitoring for Orthostatic Hypotension in Adults 60 Years and Older Being Treated with Select Antipsychotics at an Academic Medical Center.
Assessment of Opioid Withdrawal with The Clinical Opiate Withdrawal Scale (COWS) Treatment Protocol at A Community Psychiatric Hospital
Association Between Therapeutic Outcomes of Antidepressants (SSRI) and Pharmacogenetics in Patients with Neurodevelopmental Disorders
Attitudes and Perceptions About the Use of Long-Acting Injectable Antipsychotics Among Behavioral Health Providers
Benzodiazepine Prescribing Patterns at an Outpatient Family Medicine Clinic
Brand-Based Differences in Neutropenia Risk: A Case Report of Aripiprazole-induced Neutropenia
Buprenorphine Prescribing Practices in United States Emergency Departments
Burning Mouth Syndrome Responsive to Gabapentin: A Case Report
Cardiometabolic Safety of Lumateperone (ITI-007): Post Hoc Analyses of Short-Term Randomized Trials and an Open-Label Long-Term Study in Schizophrenia
Cataloguing the Impact of Psychiatric Pharmacist through Literature
Characterization of Commercial Cannabidiol Oil Products and the In-vitro Biomodulation of Citalopram and Escitalopram
Clinical Pharmacist Outreach to Improve Continuation Phase Depression Management in Adults within a Safety Net Institution
Clinical Utility of Pharmacogenomic Testing in a Veteran Mental Health Population
Clinician Perception of Initiating Buprenorphine for Patients with Opioid Use Disorder Following Virtual Simulation Experiences
Collaborative Advocacy Between Student CPNP and APhA-ASP Chapters for MFHA Inclusion Across All PharmD Curricula
Comparative Bioavailability of Amphetamine Extended-Release Oral Suspension and Extended-Release Mixed Amphetamine Salts
Comparison of Antipsychotic Prescribing Practices Following Failure of Antipsychotic Monotherapy in the Acute Care Setting
Comparison of Clozapine Dosing and Tolerability in Patients with and without Concurrent Divalproex Sodium
Comparison of Healthcare Utilization Rates Among Patients with a Stimulant Use Disorder or Opioid Use Disorder in a Veteran Population
Consumer Perception, Knowledge, and Uses of Cannabidiol
Continuation and Improvement of a Personality Disorder Treatment Protocol at a Veterans Affairs Medical Center
Deprescribing in Older Adults during Inpatient Psychiatric Hospitalization: Impact of Pharmacist Intervention and Interprofessional Collaboration
Description of Psychiatric Pharmacist-led Interventions Post Hospital Discharge within an Integrated Health System
Developing and Establishing Psychiatric and Behavioral Health Ambulatory Clinical Pharmacy Services Within a Large Heath System
Development and Implementation of a Long-Acting Injectable Procedure at a Veterans Affairs Medical Center
Development, Implementation, and Evaluation of a Clinical Tool Kit for the Care of Patients Receiving Clozapine in Acute Psychiatry
Dialectical Behavior Therapy’s Impact on Psycho-Polypharmacy Minimization in Veterans with Borderline Personality Disorder
Do Buprenorphine Doses & Ratios Matter in Medication Assisted Treatment (MAT) Retention?
Effect of A Subcutaneous Weekly and Monthly Buprenorphine (CAM2038) Extended-Release Dose on Opioid Use Disorder (OUD) Treatment Outcomes
Effect Of Pharmacogenetics-Based Decision Support Strategies In Improving Depression Outcomes: A Systematic Review
Effect of Phenobarbital on Benzodiazepine Usage for Alcohol Withdrawal
Effect of Prescriber Education on Off-Label Quetiapine Use in Veterans diagnosed with PTSD
Effectivenss Analysis of Olanzapine Compared to Other Antipsychotics for the Treatment of First-Episode Psychosis
Effects of Different Cannabidiol (CBD) Oils on the Anti-Seizure Medication Phenytoin
Effects of Early Engagement with Opioid Treatment Programs on Successful Transitions of Care
Efficacy and tolerability of KarXT (xanomeline/trospium) in a Phase 2 placebo-controlled trial in schizophrenia
Efficacy of Esketamine in Conjunction with Adjunctive Atypical Antipsychotics in Patients with Major Depressive Disorder and Active Suicidal Ideation with Intent
Efficacy of Lumateperone (ITI-007) in Depression Symptoms Associated With Schizophrenia
Efficacy of Medication Means Restriction in Veterans with High-Risk Suicide Flags
Eliminating Medications Through Patient Ownership of End Results (EMPOWER): A Reduction of Potentially Inappropriate Benzodiazepine Use In High-Risk Patients.
Evaluating Pharmacotherapy Augmentation and Progression for the Treatment of Severe Obsessive-Compulsive Disorder
Evaluating Psychotropic Medication Use in Pregnant Veterans with a Mental Illness
Evaluating The Efficacy and Safety of Switching from Onabotulinum Toxin Type A to Erenumab-aooe during COVID-19
Evaluating the Impact of a Prior Authorization Drug Request (PADR) Consult on Appropriate Initiation of Benzodiazepines Amongst Primary Care Providers
Evaluating the Impact of a Substance Use Disorder Clinical Pharmacy Specialist on Access to Care in a Mental Health Outpatient Treatment Program
Evaluating the Impact of Clinical Pharmacy Specialist in the Treatment of Alcohol Use Disorder
Evaluating the Impact of Pharmacogenetic Testing on Medication Changes in Veterans with Mental Health Conditions
Evaluating the Safety and Efficacy of Reducing Clozapine Blood Test Monitoring in Veterans Stable on Clozapine Therapy
Evaluation of Atypical Long-Acting Injectable Antipsychotics for Substance-Induced Psychosis in a Veteran Population
Evaluation of Buprenorphine for Medication Opioid Use Disorder in the Emergency Department
Evaluation of Clinical Pharmacist Management Trends for Depression
Evaluation of Clozapine-Induced Constipation and COVID-19
Evaluation of Commercially Available Cannabidiol Oils on the Metabolism of Commonly Prescribed Opioid Medications
Evaluation of Electrocardiogram (ECG) Monitoring in High Risk Patients Taking Known QTc Prolonging Drugs
Evaluation of Initial Prescribing of Benztropine or Diphenhydramine for Extrapyramidal Symptoms (EPS) in patients on Antipsychotic Therapy.
Evaluation of Once-Daily Opicapone 50 mg in Patients with Parkinson’s Disease and Motor Fluctuations: Pooled Efficacy and Safety Analyses of Two Randomized, Double-Blind, Placebo-Controlled Studies (BIPARK-1 and BIPARK-2)
Evaluation Of Oral Antipsychotics Adherence and Time To Decompensation Among Veterans With Schizophrenia
Evaluation of Outcomes in the Emergency Department Following Implementation of a Rating Scale and Order Set for Acute Agitation
Evaluation of Patients with a Diagnosis of Opiate Use Disorder Without Medication Assisted Therapy
Evaluation of Pharmacogenomic Testing
Evaluation of Pharmacogenomic Testing Utility on Restraint Use and Polypharmacy in a Forensic Psychiatric Hospital
Evaluation of Safety in Veterans Maintained on Clozapine with Nonstandard Absolute Neutrophil Count (ANC) Monitoring during the Corona Virus (COVID-19) Pandemic
Evaluation of The Appropriateness of Benzodiazepine (BZD) Prescribing.
Evaluation of the Relationship Between Opioids and Suicidality Among Veterans
Evaluation of the Safety of Intranasal Esketamine in VA using a Real Time (Prospective) MUE.
Evaluation of Treatment Outcomes of Conversion to Aripiprazole Lauroxil from Aripiprazole Monohydrate
Evaluation of Z-Drug Use in Adult Patients at a Federally Qualified Health Center
Expanding Access to Clozapine in a Veterans Affairs Community Based Outpatient Clinic (VA CBOC) Setting
Expanding Access to Naloxone with Student Pharmacists and Academic Detailing
Exploring Community Pharmacists’ Attitudes of Deregulating and Dispensing Methadone in Community Pharmacies
Factors Associated with Treatment Response in Lamotrigine Prophylaxis in Patients with Bipolar Disorder
Free and Total Serum Valproic Acid Concentrations: Association with Clinical Response and Toxicities
Health and Wellness in Pharmacy Students During the COVID-19 Pandemic
Healthcare Resource Utilization and Costs in Patients with Bipolar Disorder Treated with Lurasidone or Cariprazine: A Retrospective Analysis of Insurance Claims Data
Impact of a Neuropsychiatric Therapeutics Course and a Subsequent Case-Based Course on Mental Health Stigma among Pharmacy Students
Impact of a Pharmacist Driven Diabetes Monitoring Service in an Acute Psychiatric County Facility
Impact of a Pharmacist-led Telemental Health Transitions of Care Clinic on Psychotropic Medication Adherence
Impact of a Resident-driven Wellness Committee on Resident-perceived Wellness, Burnout, and Resilience
Impact of a Virtual Mental Health First Aid Elective Course on Stigma in Students of a Three-Year Doctor of Pharmacy Program
Impact of Clozapine Monitoring Overrides Due to COVID-19
Impact of COVID-19 Pandemic on Health Care Utilization and Overall Stability of Patients with Schizophrenia/Schizoaffective Disorder
Impact of CYP2C19 Metabolizing Phenotypes on the Treatment of Anxiety and Depression with Sertraline, Escitalopram, or Citalopram
Impact of Implementation of Stimulant Medication Order Menu on Psychostimulant Prescribing
Impact of Long-Acting Injectable Antipsychotic Administration During Psychiatric Admission versus Deferral to Outpatient Care
Impact of Non-traditional vs Traditional Initiation Dosing Schedule of Paliperidone Palmitate on Readmission and Safety
Impact of Pharmacist Interventions Related to the Safety of Long-term Corticosteroid Use in Myasthenia Gravis Patients
Impact of SARS-CoV-2 on Mental Health Education and the Adaptation to a Virtual Setting
Implementation of a long-acting injectable antipsychotic clinic at a Veterans Affairs Medical Center
Implementation of a Medication-Assisted Treatment (MAT) Program within an Inpatient Psychiatric Hospital
Implementation of a Pharmacist as the Sole Prescriber in a Primary Care Mental Health Integration Clinic at a Federal Health Care Center
Implementation of a Pharmacist-Led Intervention for the Treatment of Alcohol Use Disorder
Implementation of a Psychiatric Pharmacist in the Emergency Department
Implementation of Depression Screenings at a University-Affiliated Community Pharmacy with COVID-19 Procedure
Implementation of Pharmacy Services in Achieving Optimized Compliance to IPFQR Tobacco Use Measures
Implementation of Therapeutic Drug Monitoring in Patients on Dual Second Generation Antipsychotics in a Correctional Setting
Improvements in the Inpatient to Outpatient Transitions of Care Process for Patients Prescribed Clozapine
Improving Acute Alcohol Withdrawal Syndrome Management in a Community Based Hospital
Improving Hospital-wide Prescribing Practices through Pharmacist-initiated Physician Peer Comparison Letters
Influence of Chronobiotic-dosed Melatonin on Key Outcomes During Major Cognitive Disorder-related Geriatric Admissions
Initiation of a Benzodiazepine Tapering Clinic for Veterans with Opioid and Alcohol Use Disorders
Initiation of Antipsychotic Treatment for Amphetamine Induced Psychosis and its Impact on Length of Stay
Institution of an Acute Agitation Order Set at a Veterans Affairs Medical Center
Integration of Mental Health Clinical Pharmacy Specialists to Limit Access to Lethal Means in Veterans Identified as High Risk for Suicide
Long- and Short-Term Disability and Workers' Compensation Trends for Employees with Mental Disorders in the United States
Long- and Short-Term Disability and Workers' Compensation Trends for Employees with Substance Abuse Mental Disorders in the United States
Long-Term Antipsychotic Efficacy of Olanzapine and Samidorphan Combination in Patients With Schizophrenia: Pooled Analyses From Phase 3 Studies
Long-Term Safety of Olanzapine and Samidorphan Combination in Patients With Schizophrenia: Pooled Analyses From Phase 2 and 3 Studies
Long-Term Weight and Metabolic Effects of Olanzapine and Samidorphan Combination in Patients With Schizophrenia: Pooled Analyses From Phase 3 Studies
Longitudinal Assessment of Pharmacy Student Attitudes Towards Mental Illness
Lumateperone (ITI-007) in the Treatment of Bipolar Depression: Results from a Randomized Clinical Trial
Metabolic Monitoring in Active-Duty Soldiers Prescribed Second-Generation Antipsychotics: A Quality Improvement Project
Montelukast and Risk for Antidepressant Treatment Failure
Olanzapine and Gabapentin Combination Treatment for the Relief of Intractable Hiccups: A Case Report
Olanzapine or Clozapine with Valproic Acid Treatment in patients with Severe Mental Illness (SMI) and the Risk of COVID-19 infection at a State Psychiatric Hospital: a retrospective case control study
Olanzapine-Induced Elevated Liver Function Tests in a Patient Treated for Antidepressant-Induced Mania: A Case Report
Opioid Overdose Responder Training: Expanding Undergraduate Student Understanding and Awareness of Naloxone Use
Outcomes of Buprenorphine/Naloxone Assisted Treatment in Veterans with Opioid Use Disorder
Outcomes of Opioid and Benzodiazepine Co-Prescribing After a Prior Authorization Consult Implementation
Perceptions and Efficacy of Brexanolone for the Treatment of Postpartum Depression: A Mixed Methods Analysis
Perceptions of Adverse Drug Reactions amongst Healthcare Professionals within Inpatient State Psychiatric Facilities
Persistency and Outcomes of Pharmacist-led Screening, Brief intervention, and Referral to Treatment for Heavy Drinking in a VA Ambulatory Care Clinic
Pharmacist Attitudes Towards Transgender Patients
Pharmacist Initiated Medication Reconciliation
Pharmacist Provision of Education and Recommendations for Medications for Alcohol Use Disorder (MAUD) on an Inpatient Medical Unit
Pharmacist versus Non-Pharmacist Management on Antidepressant Adherence Rates and Associated Outcomes Among Veterans with Depressive Disorders
Pharmacist-managed Cardiovascular Risk Reduction Outcomes in Individuals Experiencing Serious Mental Illness and Diabetes Compared to Other Provider-managed Primary Care
Pharmacists Knowledge and Attitudes Regarding Cannabidiol Uses, Risks, and Adverse Events
Pharmacists’ Impact on Optimization of Benzodiazepine Use and Polypharmacy at Oregon State Hospital
Pharmacists’ Impact on Psychotropic Use in a Veterans Affairs Community Living Center
Pharmacists’ Utilization of Prescriptive Authority of Naloxone and Tobacco Cessation Products in Idaho
Pharmacogenetic Testing Implementation in a Rural Pediatric Psychiatric Hospital
Portrayal of Autism Spectrum Disorders and Related Treatments in Qatar's Printed Media
Prazosin Versus Clonidine for Treatment of Posttraumatic Stress Disorder Associated Nightmares
Predictors of Persistence and Adherence to Deutetrabenazine Among Patients With Huntington’s Disease
Predictors of Persistence and Adherence to Deutetrabenazine Among Patients With Tardive Dyskinesia
Prenatal Cannabinoid Exposure Mediated Effects On Cerebellar Oxidative Stress and Mitochondrial Function In Adolescent Rat Offspring
Prescribing Delays in Clozapine and Associated Outcomes
Prospective Pilot Study on the Clinical and Financial Outcomes of Expanding Clinical Pharmacy Services at an Inpatient Behavioral Health Center
Psychiatric Drug-Nutrient Interactions Of Vitamin D: A Retrospective Study
Psychiatric Emergency Services Recidivism and Discharge Medications
Publication Rates of PGY-2 Psychiatric Pharmacy Residency Projects and Perceived Barriers/Value to Publication
Quality of Patient Care by Converting to Injectable Antipsychotics with Longer Duration of Actions During COVID-19 Pandemic
Quantifying Anticholinergic Burden and Assessing Its Relationship With Cognitive Function in Women With and Without Schizophrenia
Racial Demographics of Patients Who Received More Than One Dose of One-Time As-Needed Injectable Antipsychotics
Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose, Parallel Group Study to Evaluate the Efficacy and Safety of the Amphetamine Extended-Release Tablet (AMPH ER TAB) in Adults with Attention-Deficit/Hyperactivity Disorder
Readmission Rates for Methamphetamine-Positive Patients Receiving Long-Acting Injectable Antipsychotics (LAIAs)
Readmission Rates of Patients Discharged from Adult Psychiatric Facilities Prescribed a Second Generation Long-acting Injectable Antipsychotic Compared to the Oral Formulation
Real-World Adherence to Tetrabenazine or Deutetrabenazine Among Patients With Huntington’s Disease
Relationship between Pharmacy Student Engagement in Curricular and Co-curricular Activities and Wellbeing
Relationship of Frequency of Lithium Administration on Time in Therapeutic Range and Treatment Effectiveness
Response and Adverse Effects of Intranasal Esketamine on a Patient Cohort in a Hospital Outpatient Clinic: A Descriptive Study.
Role of Impaired Glucose Metabolism in Treatment Outcomes for Patients with Bipolar Disorder
Ropinirole-Induced Amnesia and Hallucinations: A Case Report
Scoping Review of Policies Regarding Use of Medications for Opioid-use Disorder in Professional Recovery Programs
Seizure secondary to Fluzone Quadrivalent vaccination in a patient with severe mental illness: A case report
Societal Burden Associated with Schizophrenia Relapse among US Veterans
Specialty Pharmacist Management and Monitoring of Prescription Cannabidiol
Stimulant Prescribing Management at a Large Outpatient Facility
Stress and Substance Use Among Doctor of Pharmacy Students in a College of Pharmacy
Suicide Prevention Training “Boosters” for Student Pharmacists: Evaluation with SAVE Training
Survey of Non-Controlled Medication Misuse Patterns
Telepsychiatry for Assessing and Managing Tardive Dyskinesia: Expert Insights from a Cross-Disciplinary Virtual Treatment Panel
The COVID-19 Pandemic’s Differential Impact on the Stress Levels of Faculty Versus Administrators of US Pharmacy Schools.
The Effects of Amantadine on Individuals with Dementia-related Behaviors
The Impact of Atypical Antipsychotic Nomenclature on Patients With Bipolar Disorder: Results of a Nationwide Patient Survey
The Impact of Early Initiation of Clozapine in Veterans With Psychotic Disorders on Hospitalization, Psychiatric Hospitalization, and Mortality Rate
The Impact of Pharmacy Students' Understanding of Psychiatry on Personal Growth and Patient Treatment
The Impact of Pharmacy-Driven Physician Naloxone Training on an Inpatient Psychiatric Unit
The Impact of Selective Serotonin Reuptake Inhibitors (SSRIs) on Patient Violence and Aggression: A Retrospective Analysis
The Impact of Social Restrictions during COVID-19 on the use of as-needed/one-time (PRN/OT) psychotropic medications in an inpatient state psychiatric hospital
The Systematic Analysis of Psychiatric Outcomes in Patients Converted from 1-month to 3-month Paliperidone Palmitate Long-Acting Injections
Topiramate-Induced Renal Calculus in a Patient with Schizoaffective Disorder: A Case Report and Review of the Literature for Drug-Induced Renal Calculi
Toxic Clozapine Level as First Indication of Decreased Clearance During Severe, Acute Illness: An evaluation of concentration-to-dose ratios
Trends in Absence Time and Payments Due to Long- and Short-Term Disability and Workers' Compensation for Employees with Multiple Sclerosis in the United States
Trends in the Prescribing Patterns of Long-Acting Injectable Antipsychotics within a Psychiatric Community Health System
Understanding the Impact of COVID-19 on Schizophrenia Population Health Management: A Mixed-methods Study of Population Health Decision Makers
Use of Prescription Cannabidiol for the Management of Seizure Disorders at an Integrated Care Center
Use of Vitamin C, Vitamin D, Zinc, and Melatonin as Synergistic Adjuvant Therapy in patients with COVID-19 infection at a psychiatric hospital: a retrospective study
Using Item 8 of the Abnormal Involuntary Movement Scale (AIMS) to Assess Improvement in Patients with Tardive Dyskinesia
Utilizing MHFA-trained Student Pharmacists to Conduct Depression Screenings
Virtual Burnout: The Impact of Virtual Learning During the COVID-19 Pandemic on Perceived Stress Among Minority Pharmacy Students in an Urban Setting
Vitamin D Monitoring and Supplementation in Psychiatric Inpatients During the COVID-19 Pandemic